Biopharmaceutical Contract Manufacturing Market, By Contract Type (Active Pharmaceutical Ingredient (API) and Fill-And-Finished), By Product Type (Interferon, Monoclonal Antibodies, Protein, Vaccines, Vitamins and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2026 – 2026

  • To Be Published : Nov 2018 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell line development, fermentation, process optimization, and analytical characterization. Improved efficiency, weak product pipeline, and increasing price pressure is expected to favor the growth of biopharmaceutical contract manufacturing market in near future.

Global Biopharmaceutical Contract Manufacturing Market Taxonomy:

On the basis of contract type, product type, and therapeutic application, global biopharmaceutical contract manufacturing market is segmented into:

By Contract Type:

  • Active Pharmaceutical Ingredient (API)
  • Fill-And-Finished

By Product Type:

  • Interferons
  • Monoclonal Antibodies
  • Recombinant Hormone
  • Proteins
  • Vaccines
  • Vitamins
  • Insulin
  • Others

By Therapeutic Applications:

  • Oncology
  • Autoimmune Diseases
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Neurology
  • Infectious Diseases
  • Others

Increasing outsourcing services in biopharmaceutical industry is expected to fuel the growth of biopharmaceutical contract manufacturing market

Pelican Therapeutics and subsidiary of Heat Biologics entered into a manufacturing agreement with KBI Biopharma in September, 2017. As per the agreement, KBI biopharma will provide development and manufacturing service under biopharmaceutical contract development and manufacturing organization (CDMO) for cGMP production of an antibody (PTX-35) and a fusion protein (PTX-15). Pelican Therapeutics intends to develop immunotherapy drugs by mimicking the production of antigen-specific T-cells. In May 2016, pelican received grant around US$ 15.2 million by Cancer Prevention and Research Institute of Texas (CPRIT) to its manufacturing efforts in immunotherapies for lung, pancreatic, lymphoma, prostate, and ovarian cancers.

Ajinomoto Althea, Inc., announced a GMP production suite in newly established High Potency Products (HPP) manufacturing site located in San Diego, California, in September 2017. Currently, Althea is offering process development and analytical services to the clients and from November 2017, the company will provide facilities for GMP manufacturing of bioconjugation and complex formulation. Apart from this services, Althea is aiming to provide full manufacturing services including fill-and-finish, which will start off in 2018.

Archaogen, Inc., received contract value from Biomedical Advanced Research and Development Authority (BARDA) around US$ 18 million in the support of product development, named C-Scape in September 2017. It is an orally administered antibacterial candidate developed to treat bacterial infections caused by the family of Enterobacteriaceae producing Extended Spectrum Beta-Lactamase (ESBL).

According to the annual report of BioPlan Associates, 2017, ongoing trends influencing the biopharmaceutical manufacturing growth are increasing international manufacturing centers, which include China and expansion of biosimilars and cell-and-gene therapy approvals.

Reducing cost and focusing on core strengths is expected to fuel the growth of biopharmaceutical contract manufacturing market

According to the Journal of Pharmaceutical Manufacturing in 2017, major factors driving the growth of biopharmaceutical contract manufacturing market include minimizing risk by outsourcing with other biopharma to achieve efficient product in minimum time interval, switching over the large biopharma companies to strengthen the weak pipeline product, and to cut off the costs of product development without risking financial investments. Moreover, CMOs offer services to companies lacking the capability to develop formula or product.

The key players in biopharmaceutical contract manufacturing market include Lonza Group Ltd., ProBioGen AG, Boehringher Ingelheim, BIOMEVA GmbH, Celonic GmbH, Sandoz, Fujifilm Diosynth Biotechnology, and Rentschler Biotechnologie.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.